On the public citation graph

Recent Research Advances in Selective Matrix Metalloproteinase‐13 Inhibitors as Anti‐Osteoarthritis Agents

https://doi.org/10.1002/cmdc.201700349

0 signed · 140 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/ardp.201400200openalex-snapshot

In Silico Study Combining Docking and QSAR Methods on a Series of Matrix Metalloproteinase 13 Inhibitors

inferredcites →https://doi.org/10.1002/art.20900openalex-snapshot

Effect of inhibition of matrix metalloproteinases on cartilage loss in vitro and in a guinea pig model of osteoarthritis

inferredcites →https://doi.org/10.1002/art.24629openalex-snapshot

A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models

inferredcites →https://doi.org/10.1002/art.27596openalex-snapshot

Cartilage degradation biomarkers predict efficacy of a novel, highly selective matrix metalloproteinase 13 inhibitor in a dog model of osteoarthritis: Confirmation by multivariate analysis that modulation of type ii collagen and aggrecan degradation peptides parallels pathologic changes

inferredcites →https://doi.org/10.1002/cbic.201300698openalex-snapshot

An Integrated Computational and Experimental Approach to Gaining Selectivity for MMP‐2 within the Gelatinase Subfamily

inferredcites →https://doi.org/10.1002/cmdc.201402478openalex-snapshot

Merging Allosteric and Active Site Binding Motifs: De novo Generation of Target Selectivity and Potency via Natural‐Product‐Derived Fragments

inferredcites →https://doi.org/10.1007/s00011-009-0112-9openalex-snapshot

Novel selective MMP-13 inhibitors reduce collagen degradation in bovine articular and human osteoarthritis cartilage explants

inferredcites →https://doi.org/10.1016/j.bbamcr.2009.04.003openalex-snapshot

Matrix metalloproteinases: Fold and function of their catalytic domains

inferredcites →https://doi.org/10.1016/j.bbamcr.2009.08.006openalex-snapshot

To bind zinc or not to bind zinc: An examination of innovative approaches to improved metalloproteinase inhibition

inferredcites →https://doi.org/10.1016/j.bbapap.2011.06.020openalex-snapshot

Proteases involved in cartilage matrix degradation in osteoarthritis

inferredcites →https://doi.org/10.1016/j.biochi.2010.07.017openalex-snapshot

Third generation of matrix metalloprotease inhibitors: Gain in selectivity by targeting the depth of the S1′ cavity

inferredcites →https://doi.org/10.1016/j.bmc.2008.03.004openalex-snapshot

High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate

inferredcites →https://doi.org/10.1016/j.bmc.2014.07.025openalex-snapshot

Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: Highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1″ binding site

inferredcites →https://doi.org/10.1016/j.bmc.2016.09.009openalex-snapshot

Design, synthesis, and biological activity of novel, potent, and highly selective fused pyrimidine-2-carboxamide-4-one-based matrix metalloproteinase (MMP)-13 zinc-binding inhibitors

inferredcites →https://doi.org/10.1016/j.bmcl.2004.12.016openalex-snapshot

Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13)

inferredcites →https://doi.org/10.1016/j.bmcl.2005.02.038openalex-snapshot

Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14

inferredcites →https://doi.org/10.1016/j.bmcl.2005.04.039openalex-snapshot

Non-hydroxamate 5-phenylpyrimidine-2,4,6-trione derivatives as selective inhibitors of tumor necrosis factor-α converting enzyme

inferredcites →https://doi.org/10.1016/j.bmcl.2005.08.001openalex-snapshot

Synthesis and SAR of highly selective MMP-13 inhibitors

inferredcites →https://doi.org/10.1016/j.bmcl.2006.08.066openalex-snapshot

Potent, selective pyrimidinetrione-based inhibitors of MMP-13

inferredcites →https://doi.org/10.1016/j.bmcl.2007.09.085openalex-snapshot

Potent, selective spiropyrrolidine pyrimidinetrione inhibitors of MMP-13

inferredcites →https://doi.org/10.1016/j.bmcl.2009.07.008openalex-snapshot

3,4-Disubstituted benzofuran P1′ MMP-13 inhibitors: Optimization of selectivity and reduction of protein binding

inferredcites →https://doi.org/10.1016/j.bmcl.2009.07.151openalex-snapshot

Improving potency and selectivity of a new class of non-Zn-chelating MMP-13 inhibitors

inferredcites →https://doi.org/10.1016/j.bmcl.2009.11.081openalex-snapshot

Discovery of (pyridin-4-yl)-2H-tetrazole as a novel scaffold to identify highly selective matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis

inferredcites →https://doi.org/10.1016/j.bmcl.2010.04.111openalex-snapshot

MMP-13 selective isonipecotamide α-sulfone hydroxamates

inferredcites →https://doi.org/10.1016/j.bmcl.2010.04.130openalex-snapshot

Orally bioavailable dual MMP-1/MMP-14 sparing, MMP-13 selective α-sulfone hydroxamates

inferredcites →https://doi.org/10.1016/j.bmcl.2010.07.036openalex-snapshot

SAR studies of non-zinc-chelating MMP-13 inhibitors: Improving selectivity and metabolic stability

inferredcites →https://doi.org/10.1016/j.bmcl.2011.01.036openalex-snapshot

The design and synthesis of novel N-hydroxyformamide inhibitors of ADAM-TS4 for the treatment of osteoarthritis

inferredcites →https://doi.org/10.1016/j.bmcl.2011.03.095openalex-snapshot

MMP-13 selective alpha-sulfone hydroxamates: Identification of selective P1′ amides

inferredcites →https://doi.org/10.1016/j.bmcl.2011.05.075openalex-snapshot

Selective non zinc binding inhibitors of MMP13

inferredcites →https://doi.org/10.1016/j.bmcl.2011.08.087openalex-snapshot

Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13

inferredcites →https://doi.org/10.1016/j.bmcl.2011.09.077openalex-snapshot

Identification of novel, exosite-binding matrix metalloproteinase-13 inhibitor scaffolds

inferredcites →https://doi.org/10.1016/j.bmcl.2011.11.034openalex-snapshot

Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2

inferredcites →https://doi.org/10.1016/j.bmcl.2013.05.089openalex-snapshot

Hydantoin based inhibitors of MMP13—Discovery of AZD6605

inferredcites →https://doi.org/10.1016/j.chembiol.2004.11.014openalex-snapshot

Structural Basis for the Highly Selective Inhibition of MMP-13

inferredcites →https://doi.org/10.1016/j.ejmech.2011.10.035openalex-snapshot

Identification of novel molecular scaffolds for the design of MMP-13 inhibitors: A first round of lead optimization

inferredcites →https://doi.org/10.1016/j.ejmech.2012.10.016openalex-snapshot

Sulphonamides: Deserving class as MMP inhibitors?

inferredcites →https://doi.org/10.1016/j.jmgm.2013.06.005openalex-snapshot

Potent inhibitors precise to S1′ loop of MMP-13, a crucial target for osteoarthritis

inferredcites →https://doi.org/10.1016/j.joca.2004.08.008openalex-snapshot

Regulation of MMP-13 expression by RUNX2 and FGF2 in osteoarthritic cartilage

inferredcites →https://doi.org/10.1016/j.tox.2009.01.006openalex-snapshot

Assessment of the renal toxicity of novel anti-inflammatory compounds using cynomolgus monkey and human kidney cells

inferredcites →https://doi.org/10.1021/acs.jmedchem.5b01144openalex-snapshot

Discovery of 1,1′-Biphenyl-4-sulfonamides as a New Class of Potent and Selective Carbonic Anhydrase XIV Inhibitors

inferredcites →https://doi.org/10.1021/acs.jmedchem.5b01434openalex-snapshot

Discovery ofN-(4-Fluoro-3-methoxybenzyl)-6-(2-(((2S,5R)-5-(hydroxymethyl)-1,4-dioxan-2-yl)methyl)-2H-tetrazol-5-yl)-2-methylpyrimidine-4-carboxamide. A Highly Selective and Orally Bioavailable Matrix Metalloproteinase-13 Inhibitor for the Potential Treatment of Osteoarthritis

inferredcites →https://doi.org/10.1021/acs.jmedchem.6b01007openalex-snapshot

Discovery of Novel, Highly Potent, and Selective Matrix Metalloproteinase (MMP)-13 Inhibitors with a 1,2,4-Triazol-3-yl Moiety as a Zinc Binding Group Using a Structure-Based Design Approach

inferredcites →https://doi.org/10.1021/cr1003776openalex-snapshot

Recent Developments in the Synthesis of Fused Sultams

inferredcites →https://doi.org/10.1021/jm100669jopenalex-snapshot

Orally Active MMP-1 Sparing α-Tetrahydropyranyl and α-Piperidinyl Sulfone Matrix Metalloproteinase (MMP) Inhibitors with Efficacy in Cancer, Arthritis, and Cardiovascular Disease

inferredcites →https://doi.org/10.1021/jm201129mopenalex-snapshot

Fragment-Based Discovery of Indole Inhibitors of Matrix Metalloproteinase-13

inferredcites →https://doi.org/10.1021/jm201152uopenalex-snapshot

Discovery and Evaluation of a Non-Zn Chelating, Selective Matrix Metalloproteinase 13 (MMP-13) Inhibitor for Potential Intra-articular Treatment of Osteoarthritis

inferredcites →https://doi.org/10.1021/jm500505fopenalex-snapshot

Targeting Matrix Metalloproteinases: Exploring the Dynamics of the S1′ Pocket in the Design of Selective, Small Molecule Inhibitors

inferredcites →https://doi.org/10.1021/jm500981kopenalex-snapshot

Discovery of Novel, Highly Potent, and Selective Quinazoline-2-carboxamide-Based Matrix Metalloproteinase (MMP)-13 Inhibitors without a Zinc Binding Group Using a Structure-Based Design Approach

inferredcites →https://doi.org/10.1021/jm501284eopenalex-snapshot

Characterization of Selective Exosite-Binding Inhibitors of Matrix Metalloproteinase 13 That Prevent Articular Cartilage Degradation in Vitro

inferredcites →https://doi.org/10.1021/jm701274vopenalex-snapshot

Quinazolinones and Pyrido[3,4- d ]pyrimidin-4-ones as Orally Active and Specific Matrix Metalloproteinase-13 Inhibitors for the Treatment of Osteoarthritis

inferredcites →https://doi.org/10.1021/jm801394mopenalex-snapshot

Discovery of Potent, Selective, and Orally Active Carboxylic Acid Based Inhibitors of Matrix Metalloproteinase-13

inferredcites →https://doi.org/10.1021/jm900261fopenalex-snapshot

N-O-Isopropyl Sulfonamido-Based Hydroxamates: Design, Synthesis and Biological Evaluation of Selective Matrix Metalloproteinase-13 Inhibitors as Potential Therapeutic Agents for Osteoarthritis

inferredcites →https://doi.org/10.1038/cr.1998.17openalex-snapshot

Complex role of matrix metalloproteinases in angiogenesis

inferredcites →https://doi.org/10.1038/nrc745openalex-snapshot

New functions for the matrix metalloproteinases in cancer progression

inferredcites →https://doi.org/10.1042/bj3230483openalex-snapshot

Inhibition of bovine nasal cartilage degradation by selective matrix metalloproteinase inhibitors

inferredcites →https://doi.org/10.1073/pnas.0407788101openalex-snapshot

Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification

inferredcites →https://doi.org/10.1074/jbc.m703286200openalex-snapshot

Discovery and Characterization of a Novel Inhibitor of Matrix Metalloprotease-13 That Reduces Cartilage Damage in Vivo without Joint Fibroplasia Side Effects

inferredcites →https://doi.org/10.1080/09168451.2015.1056512openalex-snapshot

Development and function of follicular helper T cells

inferredcites →https://doi.org/10.1080/09168451.2016.1200456openalex-snapshot

Functional characterization of selective exosite-binding inhibitors of matrix metalloproteinase-13 (MMP-13) – experimental validation in human breast and colon cancer

inferredcites →https://doi.org/10.1111/j.1749-6632.1999.tb07734.xopenalex-snapshot

MMP‐13 and MMP‐1 Expression in Tissues of Normal Articular Joints

inferredcites →https://doi.org/10.1161/01.res.0000070112.80711.3dopenalex-snapshot

Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases

inferredcites →https://doi.org/10.1172/jci118475openalex-snapshot

Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage.

inferredcites →https://doi.org/10.1200/jco.1998.16.6.2150openalex-snapshot

Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer.

inferredcites →https://doi.org/10.1242/dev.01461openalex-snapshot

Altered endochondral bone development in matrix metalloproteinase 13-deficient mice

inferredcites →https://doi.org/10.2174/0929867043364018openalex-snapshot

The Design, Structure, and Clinical Update of Small Molecular Weight Matrix Metalloproteinase Inhibitors

inferredcites →https://doi.org/10.2174/092986708785747490openalex-snapshot

Structural Bases for Substrate and Inhibitor Recognition by Matrix Metalloproteinases

inferredcites →https://doi.org/10.2174/092986709788682092openalex-snapshot

Progress Towards the Identification of New Aggrecanase Inhibitors

inferredcites →https://doi.org/10.2174/1389200003339153openalex-snapshot

Hepatic Disposition of Electrophilic Acyl Glucuronide Conjugates

inferredcites →https://doi.org/10.2174/1568014054065186openalex-snapshot

Aggrecanase: The Family and Its Inhibitors

inferredcites →https://doi.org/10.2174/1568026615666150813150631openalex-snapshot

Non-Zinc-Binding Inhibitors of MMP-13: GRID-Based Approaches to Rationalize the Binding Process

inferredcites →https://doi.org/10.3109/14756366.2014.1000889openalex-snapshot

Kinetic characterization of 4,4′-biphenylsulfonamides as selective non-zinc binding MMP inhibitors

inferredcites →https://doi.org/10.3866/pku.whxb201311041openalex-snapshot

Predicting and Virtually Screening the Selective Inhibitors of MMP-13 over MMP-1 by Molecular Descriptors and Machine Learning Methods

inferredcites →https://doi.org/10.4103/0975-7406.106561openalex-snapshot

Current interventions in the management of knee osteoarthritis

inferredcites →https://doi.org/10.6023/a13101073openalex-snapshot

New Progress in the Device Physics of Polymer-fullerene Solar Cells

inferredcites →https://doi.org/10.6026/97320630008301openalex-snapshot

Lead identification and optimization of novel collagenase inhibitors; pharmacophore and structure based studies

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4087597openalex-extracted

Development of a Zn 2+-Chelating But Highly Selective Matrix Metalloproteinase 13 Inhibitor

inferred← citeshttps://doi.org/10.2139/ssrn.4177027openalex-extracted

Development of a Zn2+-Chelating But Highly Selective Matrix Metalloproteinase 13 Inhibitor

inferred← citeshttps://doi.org/10.1002/adfm.201802738openalex-snapshot

In Vivo Imaging of MMP‐13 Activity Using a Specific Polymer‐FRET Peptide Conjugate Detects Early Osteoarthritis and Inhibitor Efficacy

inferred← citeshttps://doi.org/10.1002/ange.201812348openalex-snapshot

Von der Natur inspiriertes Wirkstoffdesign: kristallographische Detektion eines selbstgenerierten Inhibitor‐Grundgerüsts

inferred← citeshttps://doi.org/10.1002/anie.201812348openalex-snapshot

Drug Design Inspired by Nature: Crystallographic Detection of an Auto‐Tailored Protease Inhibitor Template

inferred← citeshttps://doi.org/10.1002/chem.201805361openalex-snapshot

Design and Structural Evolution of Matrix Metalloproteinase Inhibitors

inferred← citeshttps://doi.org/10.1002/chem.202000617openalex-snapshot

Tailor‐Made Amino Acids and Fluorinated Motifs as Prominent Traits in Modern Pharmaceuticals

inferred← citeshttps://doi.org/10.1002/cmdc.202000911openalex-snapshot

Matrix Metalloproteinase 13 Inhibitors for Modulation of Osteoclastogenesis: Enhancement of Solubility and Stability

inferred← citeshttps://doi.org/10.1002/ejoc.201901551openalex-snapshot

Scalable Multicomponent Synthesis of (Hetero)aryl‐Substituted Phenyls: Focus on Metal‐Free Halogenated Biaryls, 3‐Arylindoles, and Isourolithine A Synthesis

inferred← citeshttps://doi.org/10.1007/s12013-026-02166-1openalex-snapshot

Vestitol Ameliorates Ferroptosis-Associated Features and Osteoarthritis Progression Through Modulation of the GSK3B/Nrf2/GPX4 Pathway

inferred← citeshttps://doi.org/10.1016/j.bcp.2019.02.033openalex-snapshot

Inhibition of MMPs and ADAM/ADAMTS

inferred← citeshttps://doi.org/10.1016/j.bioorg.2020.103616openalex-snapshot

Structure-based design and optimization of pyrimidine- and 1,2,4-triazolo[4,3-a]pyrimidine-based matrix metalloproteinase-10/13 inhibitors via Dimroth rearrangement towards targeted polypharmacology

inferred← citeshttps://doi.org/10.1016/j.bmc.2018.08.020openalex-snapshot

Development of matrix metalloproteinase-13 inhibitors – A structure-activity/structure-property relationship study

inferred← citeshttps://doi.org/10.1016/j.bmc.2019.02.003openalex-snapshot

Design, synthesis and biological evaluation of inhibitors of cathepsin K on dedifferentiated chondrocytes

inferred← citeshttps://doi.org/10.1016/j.bmcl.2022.129014openalex-snapshot

Development of a putative Zn2+-chelating but highly selective MMP-13 inhibitor

inferred← citeshttps://doi.org/10.1016/j.intimp.2017.11.020openalex-snapshot

The cysteinyl leukotriene receptor 1 (CysLT1R) antagonist montelukast suppresses matrix metalloproteinase-13 expression induced by lipopolysaccharide

inferred← citeshttps://doi.org/10.1016/j.jaim.2021.10.001openalex-snapshot

Comparison of Elaeagnus angustifolia L. extract and quercetin on mouse model of knee osteoarthritis

inferred← citeshttps://doi.org/10.1016/j.job.2025.100654openalex-snapshot

Effects of antigen-induced arthritis and compressive mechanical stress on condylar head of mandible

inferred← citeshttps://doi.org/10.1016/j.joca.2018.05.003openalex-snapshot

Associations between knee structural measures, circulating inflammatory factors and MMP13 in patients with knee osteoarthritis

inferred← citeshttps://doi.org/10.1016/j.joca.2021.03.013openalex-snapshot

Changes of synovial fluid biomarker levels after opening wedge high tibial osteotomy in patients with knee osteoarthritis

inferred← citeshttps://doi.org/10.1016/j.lfs.2019.116786openalex-snapshot

The role of matrix metalloproteinases in osteoarthritis pathogenesis: An updated review

inferred← citeshttps://doi.org/10.1016/j.molstruc.2018.02.054openalex-snapshot

3-Methylthio-4-phenyl-5-phenylamino-1,2,4-triazole hexabromotellurate:X-ray and computational study

inferred← citeshttps://doi.org/10.1016/j.omtm.2018.02.006openalex-snapshot

Isoliquiritigenin Inhibits IL-1β-Induced Production of Matrix Metalloproteinase in Articular Chondrocytes

inferred← citeshttps://doi.org/10.1021/acs.jmedchem.0c00352openalex-snapshot

Matrix Metalloproteinases as New Targets in Alzheimer’s Disease: Opportunities and Challenges

inferred← citeshttps://doi.org/10.1021/acs.jmedchem.2c01088openalex-snapshot

Discovery of Highly Potent and Selective Matrix Metalloproteinase-7 Inhibitors by Hybridizing the S1′ Subsite Binder with Short Peptides

inferred← citeshttps://doi.org/10.1038/s41584-023-00966-wopenalex-snapshot

Matrix metalloproteinases in arthritis: towards precision medicine

inferred← citeshttps://doi.org/10.1038/s41584-023-00979-5openalex-snapshot

Failure of cartilage regeneration: emerging hypotheses and related therapeutic strategies

inferred← citeshttps://doi.org/10.1039/c8ob02990copenalex-snapshot

From a MMP2/CK2 multitarget approach to the identification of potent and selective MMP13 inhibitors

inferred← citeshttps://doi.org/10.1039/d3tb02871bopenalex-snapshot

On-demand release of a selective MMP-13 blocker from an enzyme-responsive injectable hydrogel protects cartilage from degenerative progression in osteoarthritis

inferred← citeshttps://doi.org/10.1042/bsr20192620openalex-snapshot

Down-regulation of protease-activated receptor 2 ameliorated osteoarthritis in rats through regulation of MAPK/NF-κB signaling pathwayin vivoandin vitro

inferred← citeshttps://doi.org/10.1080/08916934.2024.2361749openalex-snapshot

Silencing of CircTRIM25/miR-138-5p/CREB1 axis promotes chondrogenesis in osteoarthritis

inferred← citeshttps://doi.org/10.1080/09168451.2018.1559718openalex-snapshot

Protective effects of calcitonin on IL-1 stimulated chondrocytes by regulating MMPs/TIMP-1 ratio via suppression of p50-NF-κB pathway

inferred← citeshttps://doi.org/10.1080/17460441.2020.1743676openalex-snapshot

Exploring the multiple binding modes of inhibitors to carbonic anhydrases for novel drug discovery

inferred← citeshttps://doi.org/10.1080/17460441.2020.1819235openalex-snapshot

Challenges with matrix metalloproteinase inhibition and future drug discovery avenues

inferred← citeshttps://doi.org/10.1080/17460441.2021.1933426openalex-snapshot

Understanding collagen interactions and their targeted regulation by novel drugs

inferred← citeshttps://doi.org/10.1111/1756-185x.13476openalex-snapshot

Estrogen reverses nicotine‐induced inflammation in chondrocytes via reducing the degradation of ECM

inferred← citeshttps://doi.org/10.1111/bph.14173openalex-snapshot

Serine proteinases in the turnover of the cartilage extracellular matrix in the joint: implications for therapeutics

inferred← citeshttps://doi.org/10.1111/febs.16127openalex-snapshot

Matrix metalloproteinase‐13 is fully activated by neutrophil elastase and inactivates its serpin inhibitor, alpha‐1 antitrypsin: Implications for osteoarthritis

inferred← citeshttps://doi.org/10.1177/1947603519858739openalex-snapshot

Effect of Combined Leukocyte-Poor Platelet-Rich Plasma and Hyaluronic Acid on Bone Marrow–Derived Mesenchymal Stem Cell and Chondrocyte Metabolism

inferred← citeshttps://doi.org/10.1186/s42825-023-00126-6openalex-snapshot

Collagenases and their inhibitors: a review

inferred← citeshttps://doi.org/10.12182/20230160110openalex-snapshot

[Developments in Research on the Relationship Between Matrix Metalloproteinases and Osteoarthritis].

inferred← citeshttps://doi.org/10.1248/bpb.b18-00207openalex-snapshot

BST106 Protects against Cartilage Damage by Inhibition of Apoptosis and Enhancement of Autophagy in Osteoarthritic Rats

inferred← citeshttps://doi.org/10.12688/f1000research.17471.1openalex-snapshot

Recent advances in understanding the regulation of metalloproteinases

inferred← citeshttps://doi.org/10.1371/journal.pone.0315913openalex-snapshot

Identification of the key role of IL-17RB in the treatment of osteoarthritis with Shaoyao Gancao decoction: Verification based on RNA-seq and bioinformatics analysis

inferred← citeshttps://doi.org/10.21608/amj.2023.273696openalex-snapshot

EFFECT OF QUERCETIN ON INFLAMMATORY PATHWAYS IN ANIMAL MODEL OF OSTEOARTHRITIS

inferred← citeshttps://doi.org/10.21608/vmjg.2022.267720openalex-snapshot

Experimental study on synovial fluid matrix metalloproteinases in dogs affected with osteoarthritis

inferred← citeshttps://doi.org/10.2174/0929867326666181217153118openalex-snapshot

Selective MMP-13 Inhibitors: Promising Agents for the Therapy of Osteoarthritis

inferred← citeshttps://doi.org/10.21873/invivo.12938openalex-snapshot

Condylar Resorption Following Compressive Mechanical Stress in Rabbit Model - Association of Matrix Metalloproteinases

inferred← citeshttps://doi.org/10.22203/ecm.v045a08openalex-snapshot

Disrupting mechanical homeostasis promotes matrix metalloproteinase-13 mediated processing of neuron glial antigen 2 in mandibular condylar cartilage

inferred← citeshttps://doi.org/10.3389/fcell.2021.719898openalex-snapshot

CircPan3 Promotes the Ghrelin System and Chondrocyte Autophagy by Sponging miR-667-5p During Rat Osteoarthritis Pathogenesis

inferred← citeshttps://doi.org/10.3390/cells8090984openalex-snapshot

The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma

inferred← citeshttps://doi.org/10.3390/ijms20030511openalex-snapshot

Moderate Physical Activity as a Prevention Method for Knee Osteoarthritis and the Role of Synoviocytes as Biological Key

inferred← citeshttps://doi.org/10.3390/ijms21249739openalex-snapshot

The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases

inferred← citeshttps://doi.org/10.3390/ijms22041742openalex-snapshot

Overview of MMP-13 as a Promising Target for the Treatment of Osteoarthritis

inferred← citeshttps://doi.org/10.3390/ijms22189976openalex-snapshot

Design and Synthesis of Water-Soluble and Potent MMP-13 Inhibitors with Activity in Human Osteosarcoma Cells

inferred← citeshttps://doi.org/10.3390/ijms241311098openalex-snapshot

Identification of N-Acyl Hydrazones as New Non-Zinc-Binding MMP-13 Inhibitors by Structure-Based Virtual Screening Studies and Chemical Optimization

inferred← citeshttps://doi.org/10.3390/molecules24234355openalex-snapshot

Matrix Metalloproteinase Triple-Helical Peptide Inhibitors: Potential Cross-Reactivity with Caspase-11

inferred← citeshttps://doi.org/10.3390/ph14020085openalex-snapshot

(2-Aminobenzothiazole)-Methyl-1,1-Bisphosphonic Acids: Targeting Matrix Metalloproteinase 13 Inhibition to the Bone

inferred← citeshttps://doi.org/10.3390/ph14020126openalex-snapshot

Targeting Cartilage Degradation in Osteoarthritis

inferred← citeshttps://doi.org/10.3892/ijmm.2019.4240openalex-snapshot

Long non-coding RNA XIST promotes extracellular matrix degradation by functioning as a competing endogenous RNA of miR-1277-5p in osteoarthritis

inferred← citeshttps://doi.org/10.4049/jimmunol.2101160openalex-snapshot

The Developmental Transcription Factor p63 Is Redeployed to Drive Allergic Skin Inflammation through Phosphorylation by p38α

inferred← citeshttps://doi.org/10.4314/ahs.v23i2.40openalex-snapshot

Effects of ozone combined with articular injection of sodium hyaluronate on patients with knee osteoarthritis and their inflammatory factors and hemorheological indices

inferred← citeshttps://doi.org/10.5772/67903openalex-snapshot

Cartilage Repair and Regeneration

inferred← citeshttps://doi.org/10.5772/intechopen.72478openalex-snapshot

Alternative Therapeutic Approach for Cartilage Repair

inferred← citeshttps://doi.org/10.70675/a2a691b7zbde1z435ezac62ze79e3310bff0openalex-snapshot

Conception, synthèse et évaluation biologique d'inhibiteurs de MT5-MMP : nouvelle cible d'intéret thérapeutique potentiel dans le traitement de la maladie d'Alzheimer

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.